Review



secondary antibody  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Vector Laboratories secondary antibody
    Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 753 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/10__1016_slash_j__celbio__2026__100594-284-18-26
    Average 95 stars, based on 753 article reviews
    secondary antibody - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform
    Article Snippet: .. Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS. .. After that, cells were kept in the blocking solution and observed using a fluorescence microscope (Eclipse Ti-E, Nikon, Tokyo, Japan) under standard culture conditions (37 °C, 95% humidity, 5% CO 2 ).

    Blocking Assay:

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform
    Article Snippet: .. Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS. .. After that, cells were kept in the blocking solution and observed using a fluorescence microscope (Eclipse Ti-E, Nikon, Tokyo, Japan) under standard culture conditions (37 °C, 95% humidity, 5% CO 2 ).

    Article Title: Antibody and chimeric antigen receptor (CAR) binding to CD70, and application thereof
    Article Snippet: Main Materials and Reagents: Helper phage KO7, Thermo/Invitrogen, 18311019 Streptavidin, Pierce, 21125 Biotinylated Human CD27 Ligand, HIS, Avitag, ACRO biosystem, CDL-H82Q9; High binding ELISA plate, Costar, #3590 Corning 96 Well Clear Round Bottom TC-Treated Microplate, Costar, #3799 Blocking solution: PBS+3% BSA Rinse solution: PBS+0.1% Tween20 Soluble one-component TMB substrate solution, Tiangen, PA-107-02 Anti-M13 Bacteriophage Coat Protein g8p antibody, abcam, ab9225 HRP Goat anti-mouse IgG (minimal x-reactivity) Antibody, Biolegend, 405306 FITC horse anti mouse-IgG(H+L), Vector, FI2000 Experimental Results Monoclonal phages were randomly picked from the enriched phage antibody pool, and packaged into phages. .. Main Materials and Reagents: Helper phage KO7, Thermo/Invitrogen, 18311019 Streptavidin, Pierce, 21125 Biotinylated Human CD27 Ligand, HIS, Avitag, ACRO biosystem, CDL-H82Q9; High binding ELISA plate, Costar, #3590 Corning 96 Well Clear Round Bottom TC-Treated Microplate, Costar, #3799 Blocking solution: PBS+3% BSA Rinse solution: PBS+0.1% Tween20 Soluble one-component TMB substrate solution, Tiangen, PA-107-02 Anti-M13 Bacteriophage Coat Protein g8p antibody, abcam, ab9225 HRP Goat anti-mouse IgG (minimal x-reactivity) Antibody, Biolegend, 405306 FITC horse anti mouse-IgG(H+L), Vector, FI2000 Experimental Results Monoclonal phages were randomly picked from the enriched phage antibody pool, and packaged into phages. ..

    Staining:

    Article Title: A long-acting injectable nanoparticle-hydrogel depot enables sustained IGF-1 delivery to reverse chronic denervation
    Article Snippet: .. Sections 10-μm thick were cut, then stained with a primary antibody against laminin-γ1 (MAB1920) and subsequently with a secondary antibody (fluorescein horse anti-mouse IgG antibody, Fl-2000, Vector Laboratories, Burlingame, CA). .. Average singlemyofiber CSA (μm2) was quantified using ImageJ software, in a blinded manner, and at least 350 randomly sampled myofibers were counted per sample.

    Binding Assay:

    Article Title: Antibody and chimeric antigen receptor (CAR) binding to CD70, and application thereof
    Article Snippet: Main Materials and Reagents: Helper phage KO7, Thermo/Invitrogen, 18311019 Streptavidin, Pierce, 21125 Biotinylated Human CD27 Ligand, HIS, Avitag, ACRO biosystem, CDL-H82Q9; High binding ELISA plate, Costar, #3590 Corning 96 Well Clear Round Bottom TC-Treated Microplate, Costar, #3799 Blocking solution: PBS+3% BSA Rinse solution: PBS+0.1% Tween20 Soluble one-component TMB substrate solution, Tiangen, PA-107-02 Anti-M13 Bacteriophage Coat Protein g8p antibody, abcam, ab9225 HRP Goat anti-mouse IgG (minimal x-reactivity) Antibody, Biolegend, 405306 FITC horse anti mouse-IgG(H+L), Vector, FI2000 Experimental Results Monoclonal phages were randomly picked from the enriched phage antibody pool, and packaged into phages. .. Main Materials and Reagents: Helper phage KO7, Thermo/Invitrogen, 18311019 Streptavidin, Pierce, 21125 Biotinylated Human CD27 Ligand, HIS, Avitag, ACRO biosystem, CDL-H82Q9; High binding ELISA plate, Costar, #3590 Corning 96 Well Clear Round Bottom TC-Treated Microplate, Costar, #3799 Blocking solution: PBS+3% BSA Rinse solution: PBS+0.1% Tween20 Soluble one-component TMB substrate solution, Tiangen, PA-107-02 Anti-M13 Bacteriophage Coat Protein g8p antibody, abcam, ab9225 HRP Goat anti-mouse IgG (minimal x-reactivity) Antibody, Biolegend, 405306 FITC horse anti mouse-IgG(H+L), Vector, FI2000 Experimental Results Monoclonal phages were randomly picked from the enriched phage antibody pool, and packaged into phages. ..

    Enzyme-linked Immunosorbent Assay:

    Article Title: Antibody and chimeric antigen receptor (CAR) binding to CD70, and application thereof
    Article Snippet: Main Materials and Reagents: Helper phage KO7, Thermo/Invitrogen, 18311019 Streptavidin, Pierce, 21125 Biotinylated Human CD27 Ligand, HIS, Avitag, ACRO biosystem, CDL-H82Q9; High binding ELISA plate, Costar, #3590 Corning 96 Well Clear Round Bottom TC-Treated Microplate, Costar, #3799 Blocking solution: PBS+3% BSA Rinse solution: PBS+0.1% Tween20 Soluble one-component TMB substrate solution, Tiangen, PA-107-02 Anti-M13 Bacteriophage Coat Protein g8p antibody, abcam, ab9225 HRP Goat anti-mouse IgG (minimal x-reactivity) Antibody, Biolegend, 405306 FITC horse anti mouse-IgG(H+L), Vector, FI2000 Experimental Results Monoclonal phages were randomly picked from the enriched phage antibody pool, and packaged into phages. .. Main Materials and Reagents: Helper phage KO7, Thermo/Invitrogen, 18311019 Streptavidin, Pierce, 21125 Biotinylated Human CD27 Ligand, HIS, Avitag, ACRO biosystem, CDL-H82Q9; High binding ELISA plate, Costar, #3590 Corning 96 Well Clear Round Bottom TC-Treated Microplate, Costar, #3799 Blocking solution: PBS+3% BSA Rinse solution: PBS+0.1% Tween20 Soluble one-component TMB substrate solution, Tiangen, PA-107-02 Anti-M13 Bacteriophage Coat Protein g8p antibody, abcam, ab9225 HRP Goat anti-mouse IgG (minimal x-reactivity) Antibody, Biolegend, 405306 FITC horse anti mouse-IgG(H+L), Vector, FI2000 Experimental Results Monoclonal phages were randomly picked from the enriched phage antibody pool, and packaged into phages. ..

    other:

    Article Title: p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program
    Article Snippet: Once cells began to proliferate, they were sorted based on Epithelial Cell Adhesion Molecule (EpCAM) positivity with a mouse anti-EpCAM antibody (BioLegend, cat. #118213, RRID: AB_1134105; 0.2 μg per 1 × 10 6 cells) and kept in N5 media until proliferating.

    Sterility:

    Article Title: Therapeutic targeting of blood-derived protein infiltration to modulate neuroinflammation in cerebellar ataxia.
    Article Snippet: AR TIC LE IN PR ES S ARTICLE IN PRESS Technologies, Inc., Cat#: HCP2‐0010; Essex Junction, VT, USA), 10 kDa fluorescein isothiocyanate (FITC)–dextran (Thermo Fisher Scientific, Cat#: D1820, Waltham, MA, USA), rivaroxaban (Selleckchem, Cat#: 366789‐02‐8; Houston, TX, USA), caffeine (Sigma-Aldrich, Cat#: 58‐08‐2; St. Louis, MO, USA), rabbit anti‐zonula occludens‐1 (ZO‐1; Thermo Fisher Scientific, Cat#: 61‐7300; Waltham, MA, USA), rabbit anti‐cluster of differentiation 31 (CD31; Thermo Fisher Scientific, Cat#: PA5‐16301, Waltham, MA, USA), sheep anti‐prothrombin fragment 2 (pKr-2 marker; Fitzgerald Industries, Cat#: 70R‐10587; Acton, MA, USA), mouse anti‐prothrombin (which recognizes an epitope in the pKr‐2 domain of prothrombin; Haematologic Technologies Inc., Cat#: AMP‐9013, VT, USA), rabbit anti‐prothrombin (Thermo Fisher Scientific, Cat#: PA5‐77976; Rockford, IL, USA), rabbit anti‐thrombin (Abcam, Cat#: ab92621; Cambridge, UK), rabbit anti-calbindin (Swant, Cat#: CB38, Burgdorf, Switzerland), rabbit anti-neuronal nuclei (NeuN; Cell Signaling Technology, Cat#: CST24306, Beverly, MA, USA), rabbit anti‐ionized calcium‐binding adapter molecule 1 (Iba1; Wako Pure Chemical Industries, Cat#: 019‐19741; Osaka, Japan), rabbit anti-glial fibrillary acidic protein (GFAP; Abcam, Cat#: ab68428, Cambridge, UK), rabbit anti-tumor necrosis factor-alpha (TNF-α, Abcam, Cat#: ab6671, Cambridge, UK), rabbit anti-interleukin-1 beta (IL-1β, Abcam, Cat#: ab9722, Cambridge, UK), rabbit anti-inducible nitric oxide synthase (iNOS, Abcam, Cat#: ab3523; Cambridge, UK), rat anti-cluster of differentiation 86 (CD86; Thermo Fisher Scientific, Cat# : 14-0862-81, Waltham, MA, USA), rabbit anti-toll like receptor 4 (TLR4; Santa Cruz Biotechnology, Cat#: sc‐293072, .. AR TIC LE IN PR ES S ARTICLE IN PRESS Dallas, TX, USA), rabbit anti-phospho-c-Jun (p-c-Jun; Cell Signaling Technology, Cat#: CST3270, Beverly, MA, USA), rabbit anti-c-Jun (Cell Signaling Technology, Cat#: CST9165S, Beverly, MA, USA), rabbit antiPU.1 (Cell Signaling Technology, Cat#: CST2258, Beverly, MA, USA), rabbit anti-ataxin-2 (ProteinTech, Cat#: 21776-1-AP; Rosemont, IL, USA), and mouse anti‐β‐actin (Santa Cruz Biotechnology, Cat#: sc‐47778; Dallas, TX, USA). biotinylated anti‐rabbit immunoglobulin G (IgG; Vector Laboratories, Cat#: BA‐1000, Burlingame; CA, USA), Texas Redconjugated anti-rabbit IgG (Vector Laboratories, Cat#: TI-1000, Burlingame, CA, USA), FITC-conjugated anti-mouse IgG (Vector Laboratories, Cat#: FI-2000, Burlingame, CA, USA), Alexa Fluor 488 antirat IgG (Thermo Fisher Scientific, Cat#: A-21208, Waltham, MA, USA), horseradish peroxidase (HRP)‐conjugated anti‐rabbit IgG (Enzo Life Sciences, Cat#: ADI‐SAB‐300; Farmingdale, NY, USA), HRP‐conjugated anti‐mouse IgG (Thermo Fisher Scientific, Cat#: 61‐6520; Waltham, MA, USA), HRP‐conjugated anti‐sheep IgG (GenWay Biotech Inc., Cat#: GWB‐3E18C4; San Diego, CA, USA), sterile phosphate-buffered saline (PBS) was used as the vehicle to dissolve pKr‐2. ..

    Saline:

    Article Title: Therapeutic targeting of blood-derived protein infiltration to modulate neuroinflammation in cerebellar ataxia.
    Article Snippet: AR TIC LE IN PR ES S ARTICLE IN PRESS Technologies, Inc., Cat#: HCP2‐0010; Essex Junction, VT, USA), 10 kDa fluorescein isothiocyanate (FITC)–dextran (Thermo Fisher Scientific, Cat#: D1820, Waltham, MA, USA), rivaroxaban (Selleckchem, Cat#: 366789‐02‐8; Houston, TX, USA), caffeine (Sigma-Aldrich, Cat#: 58‐08‐2; St. Louis, MO, USA), rabbit anti‐zonula occludens‐1 (ZO‐1; Thermo Fisher Scientific, Cat#: 61‐7300; Waltham, MA, USA), rabbit anti‐cluster of differentiation 31 (CD31; Thermo Fisher Scientific, Cat#: PA5‐16301, Waltham, MA, USA), sheep anti‐prothrombin fragment 2 (pKr-2 marker; Fitzgerald Industries, Cat#: 70R‐10587; Acton, MA, USA), mouse anti‐prothrombin (which recognizes an epitope in the pKr‐2 domain of prothrombin; Haematologic Technologies Inc., Cat#: AMP‐9013, VT, USA), rabbit anti‐prothrombin (Thermo Fisher Scientific, Cat#: PA5‐77976; Rockford, IL, USA), rabbit anti‐thrombin (Abcam, Cat#: ab92621; Cambridge, UK), rabbit anti-calbindin (Swant, Cat#: CB38, Burgdorf, Switzerland), rabbit anti-neuronal nuclei (NeuN; Cell Signaling Technology, Cat#: CST24306, Beverly, MA, USA), rabbit anti‐ionized calcium‐binding adapter molecule 1 (Iba1; Wako Pure Chemical Industries, Cat#: 019‐19741; Osaka, Japan), rabbit anti-glial fibrillary acidic protein (GFAP; Abcam, Cat#: ab68428, Cambridge, UK), rabbit anti-tumor necrosis factor-alpha (TNF-α, Abcam, Cat#: ab6671, Cambridge, UK), rabbit anti-interleukin-1 beta (IL-1β, Abcam, Cat#: ab9722, Cambridge, UK), rabbit anti-inducible nitric oxide synthase (iNOS, Abcam, Cat#: ab3523; Cambridge, UK), rat anti-cluster of differentiation 86 (CD86; Thermo Fisher Scientific, Cat# : 14-0862-81, Waltham, MA, USA), rabbit anti-toll like receptor 4 (TLR4; Santa Cruz Biotechnology, Cat#: sc‐293072, .. AR TIC LE IN PR ES S ARTICLE IN PRESS Dallas, TX, USA), rabbit anti-phospho-c-Jun (p-c-Jun; Cell Signaling Technology, Cat#: CST3270, Beverly, MA, USA), rabbit anti-c-Jun (Cell Signaling Technology, Cat#: CST9165S, Beverly, MA, USA), rabbit antiPU.1 (Cell Signaling Technology, Cat#: CST2258, Beverly, MA, USA), rabbit anti-ataxin-2 (ProteinTech, Cat#: 21776-1-AP; Rosemont, IL, USA), and mouse anti‐β‐actin (Santa Cruz Biotechnology, Cat#: sc‐47778; Dallas, TX, USA). biotinylated anti‐rabbit immunoglobulin G (IgG; Vector Laboratories, Cat#: BA‐1000, Burlingame; CA, USA), Texas Redconjugated anti-rabbit IgG (Vector Laboratories, Cat#: TI-1000, Burlingame, CA, USA), FITC-conjugated anti-mouse IgG (Vector Laboratories, Cat#: FI-2000, Burlingame, CA, USA), Alexa Fluor 488 antirat IgG (Thermo Fisher Scientific, Cat#: A-21208, Waltham, MA, USA), horseradish peroxidase (HRP)‐conjugated anti‐rabbit IgG (Enzo Life Sciences, Cat#: ADI‐SAB‐300; Farmingdale, NY, USA), HRP‐conjugated anti‐mouse IgG (Thermo Fisher Scientific, Cat#: 61‐6520; Waltham, MA, USA), HRP‐conjugated anti‐sheep IgG (GenWay Biotech Inc., Cat#: GWB‐3E18C4; San Diego, CA, USA), sterile phosphate-buffered saline (PBS) was used as the vehicle to dissolve pKr‐2. ..



    Similar Products

    95
    Vector Laboratories secondary antibody
    Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/10__1016_slash_j__celbio__2026__100594-284-18-26
    Average 95 stars, based on 1 article reviews
    secondary antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories anti mouse igg
    Anti Mouse Igg, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pm41992320-78-87-89
    Average 95 stars, based on 1 article reviews
    anti mouse igg - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories fi2000 experimental results monoclonal phages
    Fi2000 Experimental Results Monoclonal Phages, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/us12583931-408-74-73
    Average 95 stars, based on 1 article reviews
    fi2000 experimental results monoclonal phages - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories horse anti mouse
    Horse Anti Mouse, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pm41828941-107-4-12
    Average 95 stars, based on 1 article reviews
    horse anti mouse - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories fluorescein horse anti-mouse igg antibody
    Fluorescein Horse Anti Mouse Igg Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/custom%40fi-2000%4041808009
    Average 95 stars, based on 1 article reviews
    fluorescein horse anti-mouse igg antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories anti mouse fluorescein isothiocyanate fitc
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Anti Mouse Fluorescein Isothiocyanate Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc13088578-186-5-11
    Average 95 stars, based on 1 article reviews
    anti mouse fluorescein isothiocyanate fitc - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories horse
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Horse, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc12877752-265-23-25
    Average 95 stars, based on 1 article reviews
    horse - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories anti mouse fitc
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Anti Mouse Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc12877752-265-24-25
    Average 95 stars, based on 1 article reviews
    anti mouse fitc - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Vector Laboratories fitc
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FI-2000-1%2E5/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc12913188-62-12-13
    Average 95 stars, based on 1 article reviews
    fitc - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as ‘detection’. Anti-mouse or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence

    Journal: Cellular & Molecular Biology Letters

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform

    doi: 10.1186/s11658-025-00852-1

    Figure Lengend Snippet: Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as ‘detection’. Anti-mouse or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence

    Article Snippet: Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS.

    Techniques: Enzyme-linked Immunosorbent Assay, Derivative Assay, Affinity Purification, SDS-Gel, Staining, Transfection, Plasmid Preparation, Activity Assay, Negative Control, Recombinant

    The RSE-05 MAB binds to full-length GPA33 protein after transfection into human cells. A Validation of GPA33 expression plasmids in human cells. MCF7 cells were transfected with either HA-tagged (T) (lanes 1 and 3) or non-tagged (nT) full length GPA33 containing the transmembrane domain (lanes 2 and 4) expression plasmids, and after acquiring the cell lysates using urea lysis buffer (8 M urea in PBS), a denaturing immunoblot was processed in lanes that either contain DTT (D) (lanes 1 and 2) or without DTT in the sample loading buffer (lanes 3–5). Lysates from non-transfected MCF7 cells are in lane 5. Samples were immunoblotted with the Atlas pAb (commercial antibody), which can detect all isoforms of GPA33. The presumed monomeric form of GPA33 has a faster mobility in the absence of DTT, which presumably reflects SDS resistance of the two IgG-like lobes to denaturation due to the three di-sulphide bonds. B Analysis of RSE-05 MAB binding to GPA33 in fixed cells using immunofluorescence. C , D Analysis of RSE-05 MAB binding to cell surface localized GPA33 in living cells. MCF7 cells were mock transfected ( C ) or transfected with the GPA33 expression plasmid ( D ) and processed by flow cytometry. The data are plotted as: left panels, FITC-A is plotted as a function of FSC-A; right panels, cell count is plotted as a function of FITC-A (left panels and right panels). E MCF7 cells were stably transfected with the GPA33 expression plasmid and flow cytometry was used to isolate the positive cells (in grey) separated from the GPA33 negative cells (in red). The data are plotted as: FITC-A as a function of FSC-A stable GPA33-positive cells and GPA33-negative negative cells. F Analysis of individual GPA33 + cell clones, 3, 7 and 11. Three GPA33 stably expressing cell clones were processed by flow cytometry to measure GPA33-positive staining with the RSE-05 MAB. The data are plotted as: GPA33-positive cells as a function of FITC-A

    Journal: Cellular & Molecular Biology Letters

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform

    doi: 10.1186/s11658-025-00852-1

    Figure Lengend Snippet: The RSE-05 MAB binds to full-length GPA33 protein after transfection into human cells. A Validation of GPA33 expression plasmids in human cells. MCF7 cells were transfected with either HA-tagged (T) (lanes 1 and 3) or non-tagged (nT) full length GPA33 containing the transmembrane domain (lanes 2 and 4) expression plasmids, and after acquiring the cell lysates using urea lysis buffer (8 M urea in PBS), a denaturing immunoblot was processed in lanes that either contain DTT (D) (lanes 1 and 2) or without DTT in the sample loading buffer (lanes 3–5). Lysates from non-transfected MCF7 cells are in lane 5. Samples were immunoblotted with the Atlas pAb (commercial antibody), which can detect all isoforms of GPA33. The presumed monomeric form of GPA33 has a faster mobility in the absence of DTT, which presumably reflects SDS resistance of the two IgG-like lobes to denaturation due to the three di-sulphide bonds. B Analysis of RSE-05 MAB binding to GPA33 in fixed cells using immunofluorescence. C , D Analysis of RSE-05 MAB binding to cell surface localized GPA33 in living cells. MCF7 cells were mock transfected ( C ) or transfected with the GPA33 expression plasmid ( D ) and processed by flow cytometry. The data are plotted as: left panels, FITC-A is plotted as a function of FSC-A; right panels, cell count is plotted as a function of FITC-A (left panels and right panels). E MCF7 cells were stably transfected with the GPA33 expression plasmid and flow cytometry was used to isolate the positive cells (in grey) separated from the GPA33 negative cells (in red). The data are plotted as: FITC-A as a function of FSC-A stable GPA33-positive cells and GPA33-negative negative cells. F Analysis of individual GPA33 + cell clones, 3, 7 and 11. Three GPA33 stably expressing cell clones were processed by flow cytometry to measure GPA33-positive staining with the RSE-05 MAB. The data are plotted as: GPA33-positive cells as a function of FITC-A

    Article Snippet: Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS.

    Techniques: Transfection, Biomarker Discovery, Expressing, Lysis, Western Blot, Binding Assay, Immunofluorescence, Plasmid Preparation, Flow Cytometry, Cell Characterization, Stable Transfection, Clone Assay, Staining

    The epitope of the RSE-05 IgG is sensitive to reduction. A The indicated antibodies were used in immunoblots using purified His-tagged GPA33 protein without or with DTT in the SDS loading buffer. After incubating with the primary antibodies and adding anti-mouse or anti-rabbit HRP-conjugated secondary antibodies, membranes were stained using TMB. B ELISA was used to measure the binding activity of the RSE-05 MAB compared with the commercially available rabbit polyclonal antibody (Atlas pAb). Using GPA33 treated with the indicated chemicals (0.5% v/v SDS and/or 50 mM DTT), at different temperatures, RSE-05 and Atlas pAb (commercial antibody) binding was evaluated using anti-mouse or anti-rabbit HRP-conjugated secondary antibody, respectively. The binding activity is measured in luminescence, relative light units. C ELISA performed as in B , in this case with DTT titrated

    Journal: Cellular & Molecular Biology Letters

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform

    doi: 10.1186/s11658-025-00852-1

    Figure Lengend Snippet: The epitope of the RSE-05 IgG is sensitive to reduction. A The indicated antibodies were used in immunoblots using purified His-tagged GPA33 protein without or with DTT in the SDS loading buffer. After incubating with the primary antibodies and adding anti-mouse or anti-rabbit HRP-conjugated secondary antibodies, membranes were stained using TMB. B ELISA was used to measure the binding activity of the RSE-05 MAB compared with the commercially available rabbit polyclonal antibody (Atlas pAb). Using GPA33 treated with the indicated chemicals (0.5% v/v SDS and/or 50 mM DTT), at different temperatures, RSE-05 and Atlas pAb (commercial antibody) binding was evaluated using anti-mouse or anti-rabbit HRP-conjugated secondary antibody, respectively. The binding activity is measured in luminescence, relative light units. C ELISA performed as in B , in this case with DTT titrated

    Article Snippet: Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS.

    Techniques: Western Blot, Purification, Staining, Enzyme-linked Immunosorbent Assay, Binding Assay, Activity Assay